You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
By Justin Petrone
By Ben Butkus
Bruce Taillon, formerly the director of healthcare business development at Roche's 454 Life Sciences division, is now the head of global technology business development at Enzo Life Science.
Enzo Biochem has added four executives to lead its Enzo Life Sciences subsidiary. The new team will focus on pharmaceutical and clinical applications.
The decision allows Enzo to proceed with its lawsuit alleging Life Tech has infringed two patents covering DNA sequencing technologies.
Enzo plans to validate the test in house and then seek approval in New York State to market it as an LDT.
Increased sales for its clinical labs business offset lower revenues for its life sciences unit.
Hologic, BioMeriuex, Cornell University, Life Technologies, Samsung, Enzo Life Sciences, National Taiwan University, and others awarded US patents.
Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.
NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.
Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.
In Science this week: review discusses advances in liquid biopsies, and more.